During the time frame of the forecast, the UAE endoscopy devices market is expected to register a CAGR of 5.63 %.
The COVID-19 pandemic was expected to significantly impact the endoscopic devices market. This was mainly due to the reduction of endoscopy procedures in the initial stages of the pandemic, owing to the strict regulations imposed by the government. For instance, the SJMPS article published in February 2022 mentioned that endoscopy procedures decreased by 57% during the pandemic period in comparison with the pre-pandemic period. Such a decrease in the endoscopy procedure volume had a notable impact on the growth of the market. However, the relaxation of strict lockdown regulations, leading to an increase in endoscopy procedures during the post-pandemic period, is expected to contribute to the growth of the market over the forecast period.
The increasing preference for minimally invasive diagnostic procedures in the detection of various chronic diseases is expected to contribute to the growth of the market. For instance, the NCBI article published in November 2021 mentioned that the prevalence of colorectal cancer in the United Arab Emirates was 0.78%. Another article published in the BMC journal in August 2021 mentioned that 13.5% of the population in Abu Dhabi tested positive for colorectal cancer. Such a high incidence of colorectal cancer in the UAE is expected to drive the demand for minimally invasive procedures such as endoscopy, thereby contributing to the growth of the market. However, the lack of skilled technicians and infections caused by a lack of endoscopes are expected to restrain the growth of the market over the forecast period.
An article published in Krager in March 2021 revealed a pooled incidence rate of 2.33 per 100,000 persons per year for ulcerative colitis in the Arab world. Similarly, the UAE's pooled incidence rate for Crohn's disease was 1.46 per 100,000 people per year.Thus, there is a growing incidence of inflammatory bowel diseases in the UAE, which is expected to contribute to the growing demand for endoscopy devices, thereby contributing to the growth of the studied segment. Additionally, the Omnia Health article published in July 2021 mentioned that 3%-5% of the UAE population is affected by chronic kidney disease. The prevalence of various urological disorders is expected to drive demand for effective endoscopy procedures, contributing to the segment's growth over the forecast period.
The market is also being driven by the introduction of advanced endoscopic techniques in urology, such as robot-assisted endoscopes and disposable endoscopes.
Also, in July 2021, Scope Investment, located in the United Arab Emirates, partnered with Asan Medical Center (AMC) to open the GCC's first complete GI (gastroenterology) hospital in the United Arab Emirates. The partnership is expected to bring standards of specialized healthcare in the fields of digestive health and oncology to the UAE. Such rising investments and partnerships among various market players are expected to contribute to the growth of the studied segment in the UAE.
This product will be delivered within 2 business days.
The COVID-19 pandemic was expected to significantly impact the endoscopic devices market. This was mainly due to the reduction of endoscopy procedures in the initial stages of the pandemic, owing to the strict regulations imposed by the government. For instance, the SJMPS article published in February 2022 mentioned that endoscopy procedures decreased by 57% during the pandemic period in comparison with the pre-pandemic period. Such a decrease in the endoscopy procedure volume had a notable impact on the growth of the market. However, the relaxation of strict lockdown regulations, leading to an increase in endoscopy procedures during the post-pandemic period, is expected to contribute to the growth of the market over the forecast period.
The increasing preference for minimally invasive diagnostic procedures in the detection of various chronic diseases is expected to contribute to the growth of the market. For instance, the NCBI article published in November 2021 mentioned that the prevalence of colorectal cancer in the United Arab Emirates was 0.78%. Another article published in the BMC journal in August 2021 mentioned that 13.5% of the population in Abu Dhabi tested positive for colorectal cancer. Such a high incidence of colorectal cancer in the UAE is expected to drive the demand for minimally invasive procedures such as endoscopy, thereby contributing to the growth of the market. However, the lack of skilled technicians and infections caused by a lack of endoscopes are expected to restrain the growth of the market over the forecast period.
UAE Endoscopy Devices Market Trends
The Urology Segment is Expected to Hold the Largest Share in the UAE Endoscopy Equipment Market During the Forecast Period
Urological disorders are becoming more common in the United Arab Emirates. Additionally, the growing prevalence of urinary diseases and the increased number of ureteroscopic interventions performed in the United Arab Emirates are expected to increase the demand for endoscopic equipment, thereby driving the growth of the studied segment.An article published in Krager in March 2021 revealed a pooled incidence rate of 2.33 per 100,000 persons per year for ulcerative colitis in the Arab world. Similarly, the UAE's pooled incidence rate for Crohn's disease was 1.46 per 100,000 people per year.Thus, there is a growing incidence of inflammatory bowel diseases in the UAE, which is expected to contribute to the growing demand for endoscopy devices, thereby contributing to the growth of the studied segment. Additionally, the Omnia Health article published in July 2021 mentioned that 3%-5% of the UAE population is affected by chronic kidney disease. The prevalence of various urological disorders is expected to drive demand for effective endoscopy procedures, contributing to the segment's growth over the forecast period.
The market is also being driven by the introduction of advanced endoscopic techniques in urology, such as robot-assisted endoscopes and disposable endoscopes.
Gastroenterology is Expected to Hold Notable Share in the Market Over the Forecast Period
Gastroenterology endoscopy diagnoses the diseases prevalent in the digestive systems, such as the esophagus, stomach, intestines, liver, biliary tract, and pancreas. The rising demand for endoscopy procedures and increasing market player activities such as collaborations, partnerships, and managers to develop gastroenterology endoscopy procedures are expected to be the major factors driving the growth of the market. For instance, in September 2021, the gastroenterology team at Abu Dhabi-based Sheikh Shakhbout Medical City (SSMC), a joint-venture partnership between Mayo Clinic and Abu Dhabi Health Services Company (SEHA), introduced a cutting-edge AI system (an FDA- and UAE-approved system), GI Genius. It is an AI solution designed to assist in colonoscopy procedures.Also, in July 2021, Scope Investment, located in the United Arab Emirates, partnered with Asan Medical Center (AMC) to open the GCC's first complete GI (gastroenterology) hospital in the United Arab Emirates. The partnership is expected to bring standards of specialized healthcare in the fields of digestive health and oncology to the UAE. Such rising investments and partnerships among various market players are expected to contribute to the growth of the studied segment in the UAE.
UAE Endoscopy Devices Market Competitor Analysis
The UAE endoscopy market is competitive, with the presence of many players. The key market players include Boston Scientific Corporation, Stryker Corporation, Richard Wolf GmbH, Medtronic PLC, Johnson & Johnson, and others.Additional benefits of purchasing the report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION (Market Size by Value - USD million)
6 COMPETITIVE LANDSCAPE
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Boston Scientific Corporation
- Stryker Corporation
- Medtronic PLC
- Richard Wolf GmbH
- Johnson & Johnson
- Fujifilm Holdings
- Karl Storz GmbH & Co. KG
- Smith & Nephew PLC
- Aesculap Inc
- Cook Medical Incorporated
- C.R. Bard Inc
Methodology
LOADING...